Jennifer Diamond

Associate Professor

University of Colorado Anschutz Medical Campus

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Jing Wang

Professor

UNITED STATES

View details

Morgan MacBeth

Senior Professional Research Assistant

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Brian Freed

Professor of Medicine and Immunology

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jennifer Diamond

Research Interests

Explore related searches

Contact this professor

Articles (10)

Tackling metastatic triple-negative breast cancer with sacituzumab govitecan.

A Phase 1 Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel using a novel Randomized Continual Reassessment Method for Dose Escalation.

Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti-PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer.

Moving Towards Targeted Therapies for Triple-Negative Breast Cancer.

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.

Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials.

Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.

WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma.

A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers.

Collaborators (3)

Jing Wang

Morgan MacBeth

Brian Freed

Make your next move.